| 注册
首页|期刊导航|肿瘤预防与治疗|肿瘤免疫中树突状细胞新型亚群的发现、作用机制及树突状细胞疫苗前景

肿瘤免疫中树突状细胞新型亚群的发现、作用机制及树突状细胞疫苗前景

杨雨桐 郑婷婷 黄功华

肿瘤预防与治疗2025,Vol.38Issue(10):851-859,9.
肿瘤预防与治疗2025,Vol.38Issue(10):851-859,9.DOI:10.3969/j.issn.1674-0904.2025.10.001

肿瘤免疫中树突状细胞新型亚群的发现、作用机制及树突状细胞疫苗前景

Dendritic Cells in Tumor Immunity:Discovery of Novel Subsets,Func-tional Mechanisms,and Vaccine Applications

杨雨桐 1郑婷婷 2黄功华2

作者信息

  • 1. 523808 广东东莞,广东医科大学广东省医学免疫与分子诊断重点实验室||523808 广东东莞,广东医科大学医学技术学院
  • 2. 523808 广东东莞,广东医科大学广东省医学免疫与分子诊断重点实验室
  • 折叠

摘要

Abstract

Dendritic cells(DCs)are the most potent anti-gen-presenting cells,bridging innate and adaptive immunity.In recent years,increasing insights into the heterogeneity of DC subsets,their functional properties,and dynamic changes within the tumor microenvironment have brought significant at-tention to their roles in tumor initiation,progression,and immunotherapy.This review summarizes the phenotypic and func-tional features of newly identified DC subsets,emphasizing their roles and mechanisms in anti-tumor immunity.We further highlight recent advances in DC-based cancer vaccines and explore the potential of DCs in modulating tumor immunity.These findings provide a novel perspective for optimizing cancer immunotherapeutic strategies.

关键词

树突状细胞/肿瘤/免疫治疗

Key words

Dendritic cell/Tumor/Immunotherapy

分类

医药卫生

引用本文复制引用

杨雨桐,郑婷婷,黄功华..肿瘤免疫中树突状细胞新型亚群的发现、作用机制及树突状细胞疫苗前景[J].肿瘤预防与治疗,2025,38(10):851-859,9.

基金项目

This study was supported by grants from Guangdong Basic and Applied Basic Research Foundation(No.2022A1515140062).广东省基础与应用基础研究基金项目(编号:2022A1515140062) (No.2022A1515140062)

肿瘤预防与治疗

1674-0904

访问量0
|
下载量0
段落导航相关论文